nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—OPRD1—Amitriptyline—migraine	0.278	0.389	CbGbCtD
Remifentanil—OPRK1—Amitriptyline—migraine	0.232	0.325	CbGbCtD
Remifentanil—OPRM1—Amitriptyline—migraine	0.205	0.286	CbGbCtD
Remifentanil—OPRK1—Mecp2 and Associated Rett Syndrome—BDNF—migraine	0.000892	0.0157	CbGpPWpGaD
Remifentanil—OPRK1—Peptide GPCRs—EDNRA—migraine	0.000846	0.0149	CbGpPWpGaD
Remifentanil—OPRM1—Peptide GPCRs—EDNRA—migraine	0.000715	0.0126	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—HTR1D—migraine	0.000698	0.0123	CbGpPWpGaD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000648	0.0114	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—HTR1D—migraine	0.000612	0.0108	CbGpPWpGaD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000603	0.0106	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—RAMP1—migraine	0.000582	0.0102	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—CALCRL—migraine	0.000582	0.0102	CbGpPWpGaD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000568	0.00999	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000555	0.00976	CbGpPWpGaD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000528	0.00929	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—HTR1D—migraine	0.000518	0.0091	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000516	0.00908	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—RAMP1—migraine	0.00051	0.00897	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CALCRL—migraine	0.00051	0.00897	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000487	0.00856	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.00048	0.00844	CbGpPWpGaD
Remifentanil—OPRD1—Peptide ligand-binding receptors—TAC1—migraine	0.000476	0.00836	CbGpPWpGaD
Remifentanil—OPRD1—Peptide ligand-binding receptors—NPS—migraine	0.000476	0.00836	CbGpPWpGaD
Remifentanil—OPRD1—Peptide ligand-binding receptors—EDNRA—migraine	0.000454	0.00797	CbGpPWpGaD
Remifentanil—Pethidine—SLC6A4—migraine	0.000453	1	CrCbGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000453	0.00796	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000447	0.00785	CbGpPWpGaD
Remifentanil—Pharyngitis—Valproic Acid—migraine	0.000439	0.00194	CcSEcCtD
Remifentanil—Shock—Verapamil—migraine	0.000436	0.00193	CcSEcCtD
Remifentanil—Paraesthesia—Propranolol—migraine	0.000433	0.00191	CcSEcCtD
Remifentanil—Tachycardia—Verapamil—migraine	0.000433	0.00191	CcSEcCtD
Remifentanil—OPRM1—GPCR ligand binding—RAMP1—migraine	0.000431	0.00758	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CALCRL—migraine	0.000431	0.00758	CbGpPWpGaD
Remifentanil—Dyspnoea—Propranolol—migraine	0.00043	0.0019	CcSEcCtD
Remifentanil—Hyperhidrosis—Verapamil—migraine	0.000429	0.00189	CcSEcCtD
Remifentanil—Dysuria—Gabapentin—migraine	0.000429	0.00189	CcSEcCtD
Remifentanil—Somnolence—Propranolol—migraine	0.000429	0.00189	CcSEcCtD
Remifentanil—Visual impairment—Valproic Acid—migraine	0.000427	0.00188	CcSEcCtD
Remifentanil—Dyspepsia—Propranolol—migraine	0.000424	0.00188	CcSEcCtD
Remifentanil—Urinary retention—Topiramate—migraine	0.000424	0.00187	CcSEcCtD
Remifentanil—OPRD1—G alpha (i) signalling events—HTR1B—migraine	0.000423	0.00744	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—HTR1D—migraine	0.000423	0.00743	CbGpPWpGaD
Remifentanil—Sweating—Timolol—migraine	0.000421	0.00186	CcSEcCtD
Remifentanil—Pruritus—Amitriptyline—migraine	0.000419	0.00185	CcSEcCtD
Remifentanil—OPRK1—Peptide ligand-binding receptors—NPS—migraine	0.000417	0.00733	CbGpPWpGaD
Remifentanil—OPRK1—Peptide ligand-binding receptors—TAC1—migraine	0.000417	0.00733	CbGpPWpGaD
Remifentanil—Gastrointestinal disorder—Propranolol—migraine	0.000416	0.00184	CcSEcCtD
Remifentanil—Hypotension—Verapamil—migraine	0.000414	0.00183	CcSEcCtD
Remifentanil—Hyperglycaemia—Gabapentin—migraine	0.000414	0.00183	CcSEcCtD
Remifentanil—Pain—Propranolol—migraine	0.000412	0.00182	CcSEcCtD
Remifentanil—Constipation—Propranolol—migraine	0.000412	0.00182	CcSEcCtD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000412	0.00724	CbGpPWpGaD
Remifentanil—Pneumonia—Gabapentin—migraine	0.000411	0.00182	CcSEcCtD
Remifentanil—OPRD1—G alpha (i) signalling events—HTR1A—migraine	0.000407	0.00716	CbGpPWpGaD
Remifentanil—Hypokalaemia—Topiramate—migraine	0.000406	0.00179	CcSEcCtD
Remifentanil—Diarrhoea—Amitriptyline—migraine	0.000405	0.00179	CcSEcCtD
Remifentanil—Renal failure—Gabapentin—migraine	0.000402	0.00178	CcSEcCtD
Remifentanil—Angiopathy—Valproic Acid—migraine	0.000402	0.00177	CcSEcCtD
Remifentanil—Bradycardia—Timolol—migraine	0.000401	0.00177	CcSEcCtD
Remifentanil—Immune system disorder—Valproic Acid—migraine	0.0004	0.00177	CcSEcCtD
Remifentanil—Nasopharyngitis—Topiramate—migraine	0.000399	0.00176	CcSEcCtD
Remifentanil—Mediastinal disorder—Valproic Acid—migraine	0.000399	0.00176	CcSEcCtD
Remifentanil—Paraesthesia—Verapamil—migraine	0.000398	0.00176	CcSEcCtD
Remifentanil—OPRK1—Peptide ligand-binding receptors—EDNRA—migraine	0.000398	0.00699	CbGpPWpGaD
Remifentanil—Chills—Valproic Acid—migraine	0.000397	0.00175	CcSEcCtD
Remifentanil—Arrhythmia—Valproic Acid—migraine	0.000395	0.00175	CcSEcCtD
Remifentanil—Dyspnoea—Verapamil—migraine	0.000395	0.00175	CcSEcCtD
Remifentanil—Somnolence—Verapamil—migraine	0.000394	0.00174	CcSEcCtD
Remifentanil—OPRD1—GPCR ligand binding—HTR2B—migraine	0.000393	0.00691	CbGpPWpGaD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000393	0.0069	CbGpPWpGaD
Remifentanil—Hallucination—Timolol—migraine	0.000392	0.00173	CcSEcCtD
Remifentanil—Sweating—Gabapentin—migraine	0.000392	0.00173	CcSEcCtD
Remifentanil—Dizziness—Amitriptyline—migraine	0.000392	0.00173	CcSEcCtD
Remifentanil—Dyspepsia—Verapamil—migraine	0.00039	0.00172	CcSEcCtD
Remifentanil—Haematuria—Gabapentin—migraine	0.00039	0.00172	CcSEcCtD
Remifentanil—Dysphagia—Topiramate—migraine	0.000386	0.0017	CcSEcCtD
Remifentanil—Urticaria—Propranolol—migraine	0.000383	0.00169	CcSEcCtD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000383	0.00673	CbGpPWpGaD
Remifentanil—Body temperature increased—Propranolol—migraine	0.000381	0.00168	CcSEcCtD
Remifentanil—Visual impairment—Timolol—migraine	0.00038	0.00168	CcSEcCtD
Remifentanil—Pain—Verapamil—migraine	0.000379	0.00168	CcSEcCtD
Remifentanil—Constipation—Verapamil—migraine	0.000379	0.00168	CcSEcCtD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000378	0.00665	CbGpPWpGaD
Remifentanil—Vomiting—Amitriptyline—migraine	0.000377	0.00166	CcSEcCtD
Remifentanil—Bradycardia—Gabapentin—migraine	0.000374	0.00165	CcSEcCtD
Remifentanil—Rash—Amitriptyline—migraine	0.000373	0.00165	CcSEcCtD
Remifentanil—Dermatitis—Amitriptyline—migraine	0.000373	0.00165	CcSEcCtD
Remifentanil—OPRK1—G alpha (i) signalling events—HTR1B—migraine	0.000371	0.00652	CbGpPWpGaD
Remifentanil—Headache—Amitriptyline—migraine	0.000371	0.00164	CcSEcCtD
Remifentanil—Bronchitis—Topiramate—migraine	0.000371	0.00164	CcSEcCtD
Remifentanil—OPRK1—GPCR ligand binding—HTR1D—migraine	0.000371	0.00652	CbGpPWpGaD
Remifentanil—Abdominal discomfort—Topiramate—migraine	0.00037	0.00163	CcSEcCtD
Remifentanil—Haemorrhage—Gabapentin—migraine	0.000367	0.00162	CcSEcCtD
Remifentanil—Cardiac disorder—Timolol—migraine	0.000366	0.00162	CcSEcCtD
Remifentanil—Feeling abnormal—Verapamil—migraine	0.000366	0.00161	CcSEcCtD
Remifentanil—Hallucination—Gabapentin—migraine	0.000365	0.00161	CcSEcCtD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000365	0.00642	CbGpPWpGaD
Remifentanil—Pharyngitis—Gabapentin—migraine	0.000364	0.00161	CcSEcCtD
Remifentanil—Tremor—Valproic Acid—migraine	0.000361	0.00159	CcSEcCtD
Remifentanil—Dysuria—Topiramate—migraine	0.000361	0.00159	CcSEcCtD
Remifentanil—Angiopathy—Timolol—migraine	0.000358	0.00158	CcSEcCtD
Remifentanil—OPRK1—G alpha (i) signalling events—HTR1A—migraine	0.000357	0.00628	CbGpPWpGaD
Remifentanil—OPRM1—nerve—migraine	0.000356	0.199	CbGeAlD
Remifentanil—Anaemia—Valproic Acid—migraine	0.000356	0.00157	CcSEcCtD
Remifentanil—Immune system disorder—Timolol—migraine	0.000356	0.00157	CcSEcCtD
Remifentanil—Hypersensitivity—Propranolol—migraine	0.000355	0.00157	CcSEcCtD
Remifentanil—Mediastinal disorder—Timolol—migraine	0.000355	0.00157	CcSEcCtD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000355	0.00624	CbGpPWpGaD
Remifentanil—Agitation—Valproic Acid—migraine	0.000354	0.00156	CcSEcCtD
Remifentanil—Visual impairment—Gabapentin—migraine	0.000354	0.00156	CcSEcCtD
Remifentanil—OPRM1—Peptide ligand-binding receptors—NPS—migraine	0.000352	0.0062	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—TAC1—migraine	0.000352	0.0062	CbGpPWpGaD
Remifentanil—Urticaria—Verapamil—migraine	0.000352	0.00156	CcSEcCtD
Remifentanil—Arrhythmia—Timolol—migraine	0.000352	0.00156	CcSEcCtD
Remifentanil—Nausea—Amitriptyline—migraine	0.000352	0.00155	CcSEcCtD
Remifentanil—Hyperglycaemia—Topiramate—migraine	0.000348	0.00154	CcSEcCtD
Remifentanil—Pneumonia—Topiramate—migraine	0.000346	0.00153	CcSEcCtD
Remifentanil—OPRK1—GPCR ligand binding—HTR2B—migraine	0.000345	0.00606	CbGpPWpGaD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000344	0.00605	CbGpPWpGaD
Remifentanil—Erythema—Timolol—migraine	0.000343	0.00152	CcSEcCtD
Remifentanil—Cardiac disorder—Gabapentin—migraine	0.000341	0.0015	CcSEcCtD
Remifentanil—Renal failure—Topiramate—migraine	0.000338	0.00149	CcSEcCtD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000336	0.00591	CbGpPWpGaD
Remifentanil—Cough—Valproic Acid—migraine	0.000336	0.00149	CcSEcCtD
Remifentanil—OPRM1—Peptide ligand-binding receptors—EDNRA—migraine	0.000336	0.00591	CbGpPWpGaD
Remifentanil—Hypertension—Valproic Acid—migraine	0.000333	0.00147	CcSEcCtD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000331	0.00583	CbGpPWpGaD
Remifentanil—Immune system disorder—Gabapentin—migraine	0.000331	0.00146	CcSEcCtD
Remifentanil—Mediastinal disorder—Gabapentin—migraine	0.000331	0.00146	CcSEcCtD
Remifentanil—Diarrhoea—Propranolol—migraine	0.00033	0.00146	CcSEcCtD
Remifentanil—Chills—Gabapentin—migraine	0.000329	0.00145	CcSEcCtD
Remifentanil—OPRD1—GPCR downstream signaling—CALCRL—migraine	0.000329	0.00578	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—RAMP1—migraine	0.000329	0.00578	CbGpPWpGaD
Remifentanil—Haematuria—Topiramate—migraine	0.000328	0.00145	CcSEcCtD
Remifentanil—Anxiety—Valproic Acid—migraine	0.000327	0.00144	CcSEcCtD
Remifentanil—Hypersensitivity—Verapamil—migraine	0.000327	0.00144	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000326	0.00144	CcSEcCtD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000324	0.00569	CbGpPWpGaD
Remifentanil—Dry mouth—Valproic Acid—migraine	0.000321	0.00142	CcSEcCtD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.00032	0.00563	CbGpPWpGaD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.00032	0.00562	CbGpPWpGaD
Remifentanil—Erythema—Gabapentin—migraine	0.000319	0.00141	CcSEcCtD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000319	0.00561	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000319	0.00561	CbGpPWpGaD
Remifentanil—Dizziness—Propranolol—migraine	0.000319	0.00141	CcSEcCtD
Remifentanil—Confusional state—Valproic Acid—migraine	0.000317	0.0014	CcSEcCtD
Remifentanil—Anaphylactic shock—Valproic Acid—migraine	0.000314	0.00139	CcSEcCtD
Remifentanil—Oedema—Valproic Acid—migraine	0.000314	0.00139	CcSEcCtD
Remifentanil—Bradycardia—Topiramate—migraine	0.000314	0.00139	CcSEcCtD
Remifentanil—Pruritus—Verapamil—migraine	0.000314	0.00139	CcSEcCtD
Remifentanil—OPRM1—G alpha (i) signalling events—HTR1B—migraine	0.000314	0.00551	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—HTR1D—migraine	0.000313	0.00551	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000313	0.0055	CbGpPWpGaD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000311	0.00547	CbGpPWpGaD
Remifentanil—Haemoglobin—Topiramate—migraine	0.00031	0.00137	CcSEcCtD
Remifentanil—Haemorrhage—Topiramate—migraine	0.000309	0.00136	CcSEcCtD
Remifentanil—Nervous system disorder—Valproic Acid—migraine	0.000308	0.00136	CcSEcCtD
Remifentanil—OPRM1—TCR Signaling Pathway—FOS—migraine	0.000308	0.00542	CbGpPWpGaD
Remifentanil—Thrombocytopenia—Valproic Acid—migraine	0.000308	0.00136	CcSEcCtD
Remifentanil—Syncope—Timolol—migraine	0.000308	0.00136	CcSEcCtD
Remifentanil—Hallucination—Topiramate—migraine	0.000307	0.00136	CcSEcCtD
Remifentanil—Tachycardia—Valproic Acid—migraine	0.000307	0.00136	CcSEcCtD
Remifentanil—Vomiting—Propranolol—migraine	0.000307	0.00135	CcSEcCtD
Remifentanil—Pharyngitis—Topiramate—migraine	0.000306	0.00135	CcSEcCtD
Remifentanil—Skin disorder—Valproic Acid—migraine	0.000305	0.00135	CcSEcCtD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000304	0.00535	CbGpPWpGaD
Remifentanil—Hyperhidrosis—Valproic Acid—migraine	0.000304	0.00134	CcSEcCtD
Remifentanil—Rash—Propranolol—migraine	0.000304	0.00134	CcSEcCtD
Remifentanil—Dermatitis—Propranolol—migraine	0.000304	0.00134	CcSEcCtD
Remifentanil—Diarrhoea—Verapamil—migraine	0.000303	0.00134	CcSEcCtD
Remifentanil—OPRM1—G alpha (i) signalling events—HTR1A—migraine	0.000302	0.00531	CbGpPWpGaD
Remifentanil—Loss of consciousness—Timolol—migraine	0.000301	0.00133	CcSEcCtD
Remifentanil—Cough—Timolol—migraine	0.000299	0.00132	CcSEcCtD
Remifentanil—Tremor—Gabapentin—migraine	0.000299	0.00132	CcSEcCtD
Remifentanil—OPRD1—Signaling by GPCR—CALCRL—migraine	0.000299	0.00525	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—RAMP1—migraine	0.000299	0.00525	CbGpPWpGaD
Remifentanil—Visual impairment—Topiramate—migraine	0.000298	0.00131	CcSEcCtD
Remifentanil—Hypertension—Timolol—migraine	0.000296	0.00131	CcSEcCtD
Remifentanil—Anaemia—Gabapentin—migraine	0.000295	0.0013	CcSEcCtD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000295	0.00519	CbGpPWpGaD
Remifentanil—Hypotension—Valproic Acid—migraine	0.000294	0.0013	CcSEcCtD
Remifentanil—Agitation—Gabapentin—migraine	0.000294	0.0013	CcSEcCtD
Remifentanil—Dizziness—Verapamil—migraine	0.000293	0.0013	CcSEcCtD
Remifentanil—OPRM1—GPCR ligand binding—HTR2B—migraine	0.000291	0.00512	CbGpPWpGaD
Remifentanil—Anxiety—Timolol—migraine	0.000291	0.00129	CcSEcCtD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000291	0.00512	CbGpPWpGaD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.00029	0.00128	CcSEcCtD
Remifentanil—OPRK1—GPCR downstream signaling—RAMP1—migraine	0.000288	0.00507	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CALCRL—migraine	0.000288	0.00507	CbGpPWpGaD
Remifentanil—Cardiac disorder—Topiramate—migraine	0.000287	0.00127	CcSEcCtD
Remifentanil—Flushing—Topiramate—migraine	0.000287	0.00127	CcSEcCtD
Remifentanil—Syncope—Gabapentin—migraine	0.000286	0.00127	CcSEcCtD
Remifentanil—Nausea—Propranolol—migraine	0.000286	0.00127	CcSEcCtD
Remifentanil—Dry mouth—Timolol—migraine	0.000286	0.00126	CcSEcCtD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000284	0.00499	CbGpPWpGaD
Remifentanil—Paraesthesia—Valproic Acid—migraine	0.000282	0.00125	CcSEcCtD
Remifentanil—Confusional state—Timolol—migraine	0.000282	0.00125	CcSEcCtD
Remifentanil—Vomiting—Verapamil—migraine	0.000282	0.00125	CcSEcCtD
Remifentanil—Loss of consciousness—Gabapentin—migraine	0.000281	0.00124	CcSEcCtD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.00028	0.00493	CbGpPWpGaD
Remifentanil—Dyspnoea—Valproic Acid—migraine	0.00028	0.00124	CcSEcCtD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.00028	0.00493	CbGpPWpGaD
Remifentanil—Angiopathy—Topiramate—migraine	0.00028	0.00124	CcSEcCtD
Remifentanil—Anaphylactic shock—Timolol—migraine	0.00028	0.00124	CcSEcCtD
Remifentanil—Oedema—Timolol—migraine	0.00028	0.00124	CcSEcCtD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.00028	0.00492	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.00028	0.00492	CbGpPWpGaD
Remifentanil—Rash—Verapamil—migraine	0.00028	0.00124	CcSEcCtD
Remifentanil—Somnolence—Valproic Acid—migraine	0.00028	0.00124	CcSEcCtD
Remifentanil—Dermatitis—Verapamil—migraine	0.000279	0.00123	CcSEcCtD
Remifentanil—Immune system disorder—Topiramate—migraine	0.000279	0.00123	CcSEcCtD
Remifentanil—Cough—Gabapentin—migraine	0.000279	0.00123	CcSEcCtD
Remifentanil—Mediastinal disorder—Topiramate—migraine	0.000278	0.00123	CcSEcCtD
Remifentanil—Headache—Verapamil—migraine	0.000278	0.00123	CcSEcCtD
Remifentanil—Chills—Topiramate—migraine	0.000277	0.00122	CcSEcCtD
Remifentanil—Dyspepsia—Valproic Acid—migraine	0.000277	0.00122	CcSEcCtD
Remifentanil—Convulsion—Gabapentin—migraine	0.000277	0.00122	CcSEcCtD
Remifentanil—Hypertension—Gabapentin—migraine	0.000276	0.00122	CcSEcCtD
Remifentanil—Shock—Timolol—migraine	0.000275	0.00122	CcSEcCtD
Remifentanil—Nervous system disorder—Timolol—migraine	0.000275	0.00121	CcSEcCtD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000274	0.00482	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000274	0.00482	CbGpPWpGaD
Remifentanil—Skin disorder—Timolol—migraine	0.000272	0.0012	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Valproic Acid—migraine	0.000272	0.0012	CcSEcCtD
Remifentanil—Anxiety—Gabapentin—migraine	0.000271	0.0012	CcSEcCtD
Remifentanil—Hyperhidrosis—Timolol—migraine	0.000271	0.0012	CcSEcCtD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000271	0.00476	CbGpPWpGaD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.00027	0.00119	CcSEcCtD
Remifentanil—Constipation—Valproic Acid—migraine	0.000269	0.00119	CcSEcCtD
Remifentanil—Pain—Valproic Acid—migraine	0.000269	0.00119	CcSEcCtD
Remifentanil—Erythema—Topiramate—migraine	0.000269	0.00119	CcSEcCtD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000267	0.00469	CbGpPWpGaD
Remifentanil—Dry mouth—Gabapentin—migraine	0.000266	0.00118	CcSEcCtD
Remifentanil—Nausea—Verapamil—migraine	0.000263	0.00116	CcSEcCtD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000263	0.00463	CbGpPWpGaD
Remifentanil—Confusional state—Gabapentin—migraine	0.000263	0.00116	CcSEcCtD
Remifentanil—OPRK1—Signaling by GPCR—RAMP1—migraine	0.000262	0.0046	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CALCRL—migraine	0.000262	0.0046	CbGpPWpGaD
Remifentanil—Hypotension—Timolol—migraine	0.000262	0.00116	CcSEcCtD
Remifentanil—Oedema—Gabapentin—migraine	0.000261	0.00115	CcSEcCtD
Remifentanil—Anaphylactic shock—Gabapentin—migraine	0.000261	0.00115	CcSEcCtD
Remifentanil—Feeling abnormal—Valproic Acid—migraine	0.000259	0.00114	CcSEcCtD
Remifentanil—Shock—Gabapentin—migraine	0.000256	0.00113	CcSEcCtD
Remifentanil—OPRD1—GPCR ligand binding—HTR1B—migraine	0.000256	0.0045	CbGpPWpGaD
Remifentanil—Nervous system disorder—Gabapentin—migraine	0.000256	0.00113	CcSEcCtD
Remifentanil—Thrombocytopenia—Gabapentin—migraine	0.000255	0.00113	CcSEcCtD
Remifentanil—Tachycardia—Gabapentin—migraine	0.000254	0.00112	CcSEcCtD
Remifentanil—Skin disorder—Gabapentin—migraine	0.000253	0.00112	CcSEcCtD
Remifentanil—Hyperhidrosis—Gabapentin—migraine	0.000252	0.00111	CcSEcCtD
Remifentanil—Tremor—Topiramate—migraine	0.000252	0.00111	CcSEcCtD
Remifentanil—Paraesthesia—Timolol—migraine	0.000251	0.00111	CcSEcCtD
Remifentanil—Urticaria—Valproic Acid—migraine	0.00025	0.0011	CcSEcCtD
Remifentanil—Dyspnoea—Timolol—migraine	0.00025	0.0011	CcSEcCtD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000249	0.00438	CbGpPWpGaD
Remifentanil—Somnolence—Timolol—migraine	0.000249	0.0011	CcSEcCtD
Remifentanil—Body temperature increased—Valproic Acid—migraine	0.000249	0.0011	CcSEcCtD
Remifentanil—Anaemia—Topiramate—migraine	0.000248	0.0011	CcSEcCtD
Remifentanil—Agitation—Topiramate—migraine	0.000247	0.00109	CcSEcCtD
Remifentanil—OPRD1—GPCR ligand binding—HTR1A—migraine	0.000247	0.00434	CbGpPWpGaD
Remifentanil—Dyspepsia—Timolol—migraine	0.000246	0.00109	CcSEcCtD
Remifentanil—OPRM1—GPCR downstream signaling—CALCRL—migraine	0.000244	0.00429	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—RAMP1—migraine	0.000244	0.00429	CbGpPWpGaD
Remifentanil—Hypotension—Gabapentin—migraine	0.000244	0.00108	CcSEcCtD
Remifentanil—OPRD1—GPCR ligand binding—TAC1—migraine	0.000243	0.00427	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—NPS—migraine	0.000243	0.00427	CbGpPWpGaD
Remifentanil—Gastrointestinal disorder—Timolol—migraine	0.000242	0.00107	CcSEcCtD
Remifentanil—Syncope—Topiramate—migraine	0.000241	0.00106	CcSEcCtD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.00024	0.00422	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.00024	0.00422	CbGpPWpGaD
Remifentanil—Pain—Timolol—migraine	0.000239	0.00106	CcSEcCtD
Remifentanil—OPRD1—GPCR downstream signaling—HTR1D—migraine	0.000239	0.0042	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—HTR2C—migraine	0.000238	0.00419	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000237	0.00417	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000236	0.00416	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000236	0.00416	CbGpPWpGaD
Remifentanil—Loss of consciousness—Topiramate—migraine	0.000236	0.00104	CcSEcCtD
Remifentanil—Cough—Topiramate—migraine	0.000235	0.00104	CcSEcCtD
Remifentanil—Paraesthesia—Gabapentin—migraine	0.000234	0.00103	CcSEcCtD
Remifentanil—Convulsion—Topiramate—migraine	0.000233	0.00103	CcSEcCtD
Remifentanil—Dyspnoea—Gabapentin—migraine	0.000232	0.00103	CcSEcCtD
Remifentanil—Hypertension—Topiramate—migraine	0.000232	0.00103	CcSEcCtD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000232	0.00408	CbGpPWpGaD
Remifentanil—Somnolence—Gabapentin—migraine	0.000232	0.00102	CcSEcCtD
Remifentanil—OPRD1—GPCR ligand binding—EDNRA—migraine	0.000232	0.00407	CbGpPWpGaD
Remifentanil—Hypersensitivity—Valproic Acid—migraine	0.000232	0.00102	CcSEcCtD
Remifentanil—Feeling abnormal—Timolol—migraine	0.000231	0.00102	CcSEcCtD
Remifentanil—Dyspepsia—Gabapentin—migraine	0.000229	0.00101	CcSEcCtD
Remifentanil—Anxiety—Topiramate—migraine	0.000228	0.00101	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000227	0.001	CcSEcCtD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000225	0.00396	CbGpPWpGaD
Remifentanil—Gastrointestinal disorder—Gabapentin—migraine	0.000225	0.000994	CcSEcCtD
Remifentanil—OPRK1—GPCR ligand binding—HTR1B—migraine	0.000225	0.00395	CbGpPWpGaD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000224	0.00394	CbGpPWpGaD
Remifentanil—Dry mouth—Topiramate—migraine	0.000224	0.000989	CcSEcCtD
Remifentanil—OPRD1—GPCR ligand binding—CALCA—migraine	0.000223	0.00392	CbGpPWpGaD
Remifentanil—Pain—Gabapentin—migraine	0.000223	0.000985	CcSEcCtD
Remifentanil—Constipation—Gabapentin—migraine	0.000223	0.000985	CcSEcCtD
Remifentanil—Pruritus—Valproic Acid—migraine	0.000223	0.000983	CcSEcCtD
Remifentanil—Urticaria—Timolol—migraine	0.000222	0.000983	CcSEcCtD
Remifentanil—OPRD1—GPCR downstream signaling—HTR2B—migraine	0.000222	0.00391	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CALCRL—migraine	0.000221	0.00389	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—RAMP1—migraine	0.000221	0.00389	CbGpPWpGaD
Remifentanil—Body temperature increased—Timolol—migraine	0.000221	0.000978	CcSEcCtD
Remifentanil—Confusional state—Topiramate—migraine	0.000221	0.000977	CcSEcCtD
Remifentanil—Oedema—Topiramate—migraine	0.000219	0.000969	CcSEcCtD
Remifentanil—OPRD1—Signaling by GPCR—HTR1D—migraine	0.000217	0.00382	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—HTR1A—migraine	0.000216	0.0038	CbGpPWpGaD
Remifentanil—Shock—Topiramate—migraine	0.000216	0.000953	CcSEcCtD
Remifentanil—Diarrhoea—Valproic Acid—migraine	0.000215	0.000951	CcSEcCtD
Remifentanil—Nervous system disorder—Topiramate—migraine	0.000215	0.00095	CcSEcCtD
Remifentanil—Feeling abnormal—Gabapentin—migraine	0.000215	0.000949	CcSEcCtD
Remifentanil—Thrombocytopenia—Topiramate—migraine	0.000215	0.000949	CcSEcCtD
Remifentanil—Tachycardia—Topiramate—migraine	0.000214	0.000946	CcSEcCtD
Remifentanil—Skin disorder—Topiramate—migraine	0.000213	0.000941	CcSEcCtD
Remifentanil—OPRK1—GPCR ligand binding—NPS—migraine	0.000213	0.00374	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—TAC1—migraine	0.000213	0.00374	CbGpPWpGaD
Remifentanil—Hyperhidrosis—Topiramate—migraine	0.000212	0.000937	CcSEcCtD
Remifentanil—OPRK1—GPCR downstream signaling—HTR1D—migraine	0.00021	0.00368	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—HTR2C—migraine	0.000209	0.00367	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—HTR7—migraine	0.000209	0.00367	CbGpPWpGaD
Remifentanil—Dizziness—Valproic Acid—migraine	0.000208	0.000919	CcSEcCtD
Remifentanil—Urticaria—Gabapentin—migraine	0.000207	0.000915	CcSEcCtD
Remifentanil—Hypersensitivity—Timolol—migraine	0.000206	0.000911	CcSEcCtD
Remifentanil—Body temperature increased—Gabapentin—migraine	0.000206	0.000911	CcSEcCtD
Remifentanil—Hypotension—Topiramate—migraine	0.000205	0.000905	CcSEcCtD
Remifentanil—OPRK1—GPCR ligand binding—EDNRA—migraine	0.000203	0.00357	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000203	0.00357	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—HTR2B—migraine	0.000202	0.00355	CbGpPWpGaD
Remifentanil—Vomiting—Valproic Acid—migraine	0.0002	0.000883	CcSEcCtD
Remifentanil—Rash—Valproic Acid—migraine	0.000198	0.000876	CcSEcCtD
Remifentanil—Dermatitis—Valproic Acid—migraine	0.000198	0.000875	CcSEcCtD
Remifentanil—Pruritus—Timolol—migraine	0.000198	0.000875	CcSEcCtD
Remifentanil—Headache—Valproic Acid—migraine	0.000197	0.00087	CcSEcCtD
Remifentanil—Paraesthesia—Topiramate—migraine	0.000197	0.00087	CcSEcCtD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000196	0.00345	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CALCA—migraine	0.000196	0.00344	CbGpPWpGaD
Remifentanil—Dyspnoea—Topiramate—migraine	0.000196	0.000864	CcSEcCtD
Remifentanil—Somnolence—Topiramate—migraine	0.000195	0.000861	CcSEcCtD
Remifentanil—OPRK1—GPCR downstream signaling—HTR2B—migraine	0.000195	0.00342	CbGpPWpGaD
Remifentanil—Dyspepsia—Topiramate—migraine	0.000193	0.000853	CcSEcCtD
Remifentanil—Hypersensitivity—Gabapentin—migraine	0.000192	0.000849	CcSEcCtD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000192	0.00337	CbGpPWpGaD
Remifentanil—Diarrhoea—Timolol—migraine	0.000192	0.000846	CcSEcCtD
Remifentanil—OPRK1—Signaling by GPCR—HTR1D—migraine	0.00019	0.00335	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—HTR1B—migraine	0.00019	0.00334	CbGpPWpGaD
Remifentanil—Gastrointestinal disorder—Topiramate—migraine	0.000189	0.000837	CcSEcCtD
Remifentanil—Pain—Topiramate—migraine	0.000188	0.000829	CcSEcCtD
Remifentanil—Constipation—Topiramate—migraine	0.000188	0.000829	CcSEcCtD
Remifentanil—Nausea—Valproic Acid—migraine	0.000187	0.000825	CcSEcCtD
Remifentanil—Dizziness—Timolol—migraine	0.000185	0.000818	CcSEcCtD
Remifentanil—Pruritus—Gabapentin—migraine	0.000184	0.000815	CcSEcCtD
Remifentanil—OPRK1—GPCR ligand binding—HTR7—migraine	0.000183	0.00322	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—HTR1A—migraine	0.000183	0.00321	CbGpPWpGaD
Remifentanil—Feeling abnormal—Topiramate—migraine	0.000181	0.000799	CcSEcCtD
Remifentanil—OPRM1—GPCR ligand binding—NPS—migraine	0.00018	0.00316	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—TAC1—migraine	0.00018	0.00316	CbGpPWpGaD
Remifentanil—Diarrhoea—Gabapentin—migraine	0.000178	0.000788	CcSEcCtD
Remifentanil—Vomiting—Timolol—migraine	0.000178	0.000786	CcSEcCtD
Remifentanil—OPRM1—GPCR downstream signaling—HTR1D—migraine	0.000177	0.00311	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—HTR2B—migraine	0.000177	0.00311	CbGpPWpGaD
Remifentanil—Rash—Timolol—migraine	0.000177	0.00078	CcSEcCtD
Remifentanil—OPRM1—GPCR ligand binding—HTR2C—migraine	0.000177	0.0031	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CALCRL—migraine	0.000176	0.0031	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RAMP1—migraine	0.000176	0.0031	CbGpPWpGaD
Remifentanil—Dermatitis—Timolol—migraine	0.000176	0.000779	CcSEcCtD
Remifentanil—Headache—Timolol—migraine	0.000175	0.000775	CcSEcCtD
Remifentanil—Urticaria—Topiramate—migraine	0.000174	0.00077	CcSEcCtD
Remifentanil—Body temperature increased—Topiramate—migraine	0.000173	0.000766	CcSEcCtD
Remifentanil—Dizziness—Gabapentin—migraine	0.000172	0.000762	CcSEcCtD
Remifentanil—OPRM1—GPCR ligand binding—EDNRA—migraine	0.000172	0.00302	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000168	0.00296	CbGpPWpGaD
Remifentanil—Nausea—Timolol—migraine	0.000166	0.000735	CcSEcCtD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000166	0.00292	CbGpPWpGaD
Remifentanil—Vomiting—Gabapentin—migraine	0.000166	0.000732	CcSEcCtD
Remifentanil—OPRM1—GPCR ligand binding—CALCA—migraine	0.000165	0.00291	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—HTR2B—migraine	0.000165	0.00289	CbGpPWpGaD
Remifentanil—Rash—Gabapentin—migraine	0.000164	0.000726	CcSEcCtD
Remifentanil—Dermatitis—Gabapentin—migraine	0.000164	0.000726	CcSEcCtD
Remifentanil—Headache—Gabapentin—migraine	0.000163	0.000722	CcSEcCtD
Remifentanil—Hypersensitivity—Topiramate—migraine	0.000162	0.000714	CcSEcCtD
Remifentanil—OPRM1—Signaling by GPCR—HTR1D—migraine	0.000161	0.00283	CbGpPWpGaD
Remifentanil—Pruritus—Topiramate—migraine	0.000155	0.000686	CcSEcCtD
Remifentanil—Nausea—Gabapentin—migraine	0.000155	0.000684	CcSEcCtD
Remifentanil—OPRK1—Signaling Pathways—CALCRL—migraine	0.000155	0.00272	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RAMP1—migraine	0.000155	0.00272	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—HTR7—migraine	0.000155	0.00272	CbGpPWpGaD
Remifentanil—OPRM1—brainstem—migraine	0.000153	0.0855	CbGeAlD
Remifentanil—Diarrhoea—Topiramate—migraine	0.00015	0.000663	CcSEcCtD
Remifentanil—OPRM1—Signaling by GPCR—HTR2B—migraine	0.00015	0.00263	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—HTR2A—migraine	0.000146	0.00257	CbGpPWpGaD
Remifentanil—Dizziness—Topiramate—migraine	0.000145	0.000641	CcSEcCtD
Remifentanil—OPRD1—GPCR downstream signaling—HTR1B—migraine	0.000145	0.00255	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000142	0.0025	CbGpPWpGaD
Remifentanil—Vomiting—Topiramate—migraine	0.000139	0.000616	CcSEcCtD
Remifentanil—OPRD1—GPCR downstream signaling—HTR1A—migraine	0.000139	0.00245	CbGpPWpGaD
Remifentanil—Rash—Topiramate—migraine	0.000138	0.000611	CcSEcCtD
Remifentanil—Dermatitis—Topiramate—migraine	0.000138	0.00061	CcSEcCtD
Remifentanil—Headache—Topiramate—migraine	0.000137	0.000607	CcSEcCtD
Remifentanil—OPRD1—GPCR downstream signaling—TAC1—migraine	0.000137	0.00241	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—NPS—migraine	0.000137	0.00241	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—HTR2C—migraine	0.000135	0.00237	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—HTR1B—migraine	0.000131	0.00231	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—EDNRA—migraine	0.000131	0.0023	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RAMP1—migraine	0.000131	0.0023	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CALCRL—migraine	0.000131	0.0023	CbGpPWpGaD
Remifentanil—Nausea—Topiramate—migraine	0.00013	0.000576	CcSEcCtD
Remifentanil—OPRD1—Signaling Pathways—HTR1D—migraine	0.000128	0.00225	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—HTR2A—migraine	0.000128	0.00225	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—HTR1B—migraine	0.000127	0.00223	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—HTR1A—migraine	0.000127	0.00223	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CALCA—migraine	0.000126	0.00222	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—TAC1—migraine	0.000125	0.00219	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—NPS—migraine	0.000125	0.00219	CbGpPWpGaD
Remifentanil—OPRD1—head—migraine	0.000124	0.0693	CbGeAlD
Remifentanil—OPRD1—Signaling by GPCR—HTR2C—migraine	0.000122	0.00215	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—HTR1A—migraine	0.000122	0.00215	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—TAC1—migraine	0.00012	0.00212	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—NPS—migraine	0.00012	0.00212	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HTR2B—migraine	0.000119	0.0021	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—EDNRA—migraine	0.000119	0.00209	CbGpPWpGaD
Remifentanil—OPRK1—head—migraine	0.000119	0.0664	CbGeAlD
Remifentanil—OPRK1—GPCR downstream signaling—HTR2C—migraine	0.000118	0.00208	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—HTR7—migraine	0.000118	0.00207	CbGpPWpGaD
Remifentanil—OPRD1—nervous system—migraine	0.000117	0.0657	CbGeAlD
Remifentanil—OPRK1—Signaling by GPCR—HTR1B—migraine	0.000115	0.00203	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—EDNRA—migraine	0.000115	0.00202	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CALCA—migraine	0.000114	0.00201	CbGpPWpGaD
Remifentanil—OPRD1—central nervous system—migraine	0.000113	0.0633	CbGeAlD
Remifentanil—OPRK1—nervous system—migraine	0.000113	0.063	CbGeAlD
Remifentanil—OPRK1—Signaling Pathways—HTR1D—migraine	0.000112	0.00198	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—HTR1A—migraine	0.000111	0.00195	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CALCA—migraine	0.000111	0.00194	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—TAC1—migraine	0.000109	0.00192	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—NPS—migraine	0.000109	0.00192	CbGpPWpGaD
Remifentanil—OPRK1—central nervous system—migraine	0.000108	0.0606	CbGeAlD
Remifentanil—OPRM1—GPCR ligand binding—HTR2A—migraine	0.000108	0.0019	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—HTR1B—migraine	0.000107	0.00189	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—HTR2C—migraine	0.000107	0.00188	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—HTR7—migraine	0.000107	0.00188	CbGpPWpGaD
Remifentanil—OPRK1—cerebellum—migraine	0.000106	0.0593	CbGeAlD
Remifentanil—OPRD1—Signaling Pathways—LRP1—migraine	0.000105	0.00184	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HTR2B—migraine	0.000105	0.00184	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—EDNRA—migraine	0.000104	0.00183	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—HTR7—migraine	0.000103	0.00182	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—HTR1A—migraine	0.000103	0.00182	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—TAC1—migraine	0.000102	0.00179	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—NPS—migraine	0.000102	0.00179	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CALCA—migraine	0.0001	0.00176	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—HTR2C—migraine	9.98e-05	0.00175	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—HTR1B—migraine	9.74e-05	0.00171	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—EDNRA—migraine	9.7e-05	0.00171	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HTR1D—migraine	9.5e-05	0.00167	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—HTR7—migraine	9.39e-05	0.00165	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—HTR1A—migraine	9.38e-05	0.00165	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CALCA—migraine	9.34e-05	0.00164	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—TAC1—migraine	9.24e-05	0.00162	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—NPS—migraine	9.24e-05	0.00162	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—LRP1—migraine	9.2e-05	0.00162	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—HTR2C—migraine	9.06e-05	0.00159	CbGpPWpGaD
Remifentanil—OPRD1—brain—migraine	8.98e-05	0.0502	CbGeAlD
Remifentanil—OPRM1—Signaling Pathways—HTR2B—migraine	8.83e-05	0.00155	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—EDNRA—migraine	8.81e-05	0.00155	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—HTR7—migraine	8.74e-05	0.00154	CbGpPWpGaD
Remifentanil—OPRK1—brain—migraine	8.61e-05	0.0481	CbGeAlD
Remifentanil—OPRM1—Signaling by GPCR—CALCA—migraine	8.48e-05	0.00149	CbGpPWpGaD
Remifentanil—OPRM1—head—migraine	8.45e-05	0.0473	CbGeAlD
Remifentanil—OPRD1—GPCR downstream signaling—HTR2A—migraine	8.26e-05	0.00145	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NOTCH4—migraine	8.05e-05	0.00142	CbGpPWpGaD
Remifentanil—OPRM1—nervous system—migraine	8.01e-05	0.0448	CbGeAlD
Remifentanil—OPRM1—Signaling by GPCR—HTR7—migraine	7.93e-05	0.00139	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—LRP1—migraine	7.78e-05	0.00137	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HTR1B—migraine	7.77e-05	0.00137	CbGpPWpGaD
Remifentanil—OPRM1—central nervous system—migraine	7.71e-05	0.0431	CbGeAlD
Remifentanil—OPRD1—Signaling by GPCR—HTR2A—migraine	7.5e-05	0.00132	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HTR1A—migraine	7.48e-05	0.00131	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PGR—migraine	7.36e-05	0.00129	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TAC1—migraine	7.36e-05	0.00129	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NPS—migraine	7.36e-05	0.00129	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—HTR2A—migraine	7.24e-05	0.00127	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HTR2C—migraine	7.22e-05	0.00127	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NOTCH4—migraine	7.06e-05	0.00124	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—EDNRA—migraine	7.02e-05	0.00123	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NOTCH3—migraine	6.85e-05	0.0012	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HTR1B—migraine	6.81e-05	0.0012	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CALCA—migraine	6.76e-05	0.00119	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—HTR2A—migraine	6.58e-05	0.00116	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HTR1A—migraine	6.56e-05	0.00115	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PGR—migraine	6.46e-05	0.00114	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TAC1—migraine	6.46e-05	0.00114	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NPS—migraine	6.46e-05	0.00114	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HTR2C—migraine	6.33e-05	0.00111	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HTR7—migraine	6.32e-05	0.00111	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—EDNRA—migraine	6.16e-05	0.00108	CbGpPWpGaD
Remifentanil—OPRM1—brain—migraine	6.12e-05	0.0343	CbGeAlD
Remifentanil—OPRM1—GPCR downstream signaling—HTR2A—migraine	6.12e-05	0.00108	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NOTCH3—migraine	6e-05	0.00106	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NOTCH4—migraine	5.97e-05	0.00105	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CALCA—migraine	5.93e-05	0.00104	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HTR1B—migraine	5.76e-05	0.00101	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—HTR2A—migraine	5.56e-05	0.000977	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HTR7—migraine	5.55e-05	0.000975	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HTR1A—migraine	5.54e-05	0.000974	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PGR—migraine	5.46e-05	0.000959	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NPS—migraine	5.46e-05	0.000959	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TAC1—migraine	5.46e-05	0.000959	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TGFBR2—migraine	5.45e-05	0.000958	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HTR2C—migraine	5.35e-05	0.000941	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EDNRA—migraine	5.21e-05	0.000915	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NOTCH3—migraine	5.07e-05	0.000892	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CALCA—migraine	5.01e-05	0.000881	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TGFBR2—migraine	4.78e-05	0.00084	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HTR7—migraine	4.69e-05	0.000824	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HTR2A—migraine	4.43e-05	0.000779	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TGFBR2—migraine	4.04e-05	0.00071	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ESR1—migraine	3.93e-05	0.000691	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HTR2A—migraine	3.88e-05	0.000683	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ESR1—migraine	3.45e-05	0.000606	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HTR2A—migraine	3.28e-05	0.000577	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ESR1—migraine	2.91e-05	0.000512	CbGpPWpGaD
